CCIA
INFI

Campbell & Co Investment Adviser’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Campbell & Co Investment Adviser’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-40,127
Closed -$539K – 290
2014
Q3 		$539K Buy
+40,127
New +$478K 0.28% 117

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Campbell & Co Investment Adviser's INFI Position: Q4 2014 in Review

Campbell & Co Investment Adviser sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2014, closing a stake of 40,127 shares — an estimated $539K sold.

Campbell & Co Investment Adviser first reported a position in INFI in Q3 2014 and held it in 1 quarter. The position peaked at $539K in Q3 2014. 143 funds tracked by Wall St. Rank hold INFI as of Q4 2014.

  • Campbell & Co Investment Adviser reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 40,127 Infinity Pharmaceuticals, Inc. shares in Q4 2014, an estimated $539K.
  • Campbell & Co Investment Adviser first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Infinity Pharmaceuticals, Inc. position peaked at $539K in Q3 2014.
  • 143 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2014.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2014, filed 12 Feb 2015.